Budget Amount *help |
¥19,760,000 (Direct Cost: ¥15,200,000、Indirect Cost: ¥4,560,000)
Fiscal Year 2019: ¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000)
Fiscal Year 2018: ¥3,120,000 (Direct Cost: ¥2,400,000、Indirect Cost: ¥720,000)
Fiscal Year 2017: ¥5,980,000 (Direct Cost: ¥4,600,000、Indirect Cost: ¥1,380,000)
Fiscal Year 2016: ¥8,060,000 (Direct Cost: ¥6,200,000、Indirect Cost: ¥1,860,000)
|
Outline of Final Research Achievements |
In this program, we conducted a comprehensive analysis of association between alternative splicing and neuropsychiatric disorders. Specifically, we reported the results of genome-wide identification of splicing quantitative trait loci (sQTLs) in the human brain and analysis of their association with neuropsychiatric disorders such as schizophrenia (Takata et al., Nature Communications 2017), and large-scale exome studies of autism spectrum disorder and developmental and epileptic encephalopathy analyzing rare variants including those potentially affect alternative splicing (Takata et al., Cell Reports 2018, Takata et al., Nature Communications 2019).
|